-

Entwistle & Cappucci LLP Reports Approval of the Chapter 11 Plan of the FTX Debtors Pending Final Confirmation Order

United States Bankruptcy Approves from the Bench the Chapter 11 Plan for the FTX Debtors

AUSTIN, Texas--(BUSINESS WIRE)--Entwistle & Cappucci LLP is pleased to report that today the Honorable John T. Dorsey of the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court” or “Court”) approved from the bench the Chapter 11 Plan (the “Plan”) of FTX Trading Ltd. (d.b.a. “FTX.com”) and West Realm Shires Services, Inc. (d.b.a. “FTX.US”), and their affiliated debtors (together, the “FTX Debtors”), pending the Court’s final review of the proposed confirmation order. Included in the approved Plan is the Customer Priority Settlement announced in October 2023, which will, along with other aspects of the Plan, enable eventual distributions to FTX.com and FTX.US customers of as much as 140% of their approved customer claims. This result would not have been possible without the substantial efforts and cooperation of the FTX Debtors, and in particular CEO John Ray and the Board, the Official Committee of Unsecured Creditors and the Ad Hoc Customers Committee.

Entwistle & Cappucci LLP is continuing with the Adversary Class Action on behalf of customers in the Bankruptcy Court, Onusz et al. v. West Realm Shires, Inc. et al., Adv. Pro. No. 22-50513, against Samuel Bankman-Fried and the other insiders named in that action, except for Caroline Ellison, with whom, together with the FTX Debtors, we recently entered into a settlement that should result in substantial benefits to customers and the estates.

About Entwistle & Cappucci LLP

Entwistle & Cappucci LLP is a national law firm providing exceptional legal representation to clients in the most complex and challenging legal matters. Our practice encompasses all areas of litigation, corporate transactions, bankruptcy, insurance, corporate investigations, and white-collar defense. Our clients include public and private corporations, major hedge funds, public pension funds, governmental entities, leading institutional investors, domestic and foreign financial services companies, emerging business enterprises and individual entrepreneurs.

Contacts

Andrew J. Entwistle
Entwistle & Cappucci LLP
500 W 2nd Street, Suite 1900
Austin, TX 78701
Telephone: (512) 710-5960
Email: aentwistle@entwistle-law.com
www.entwistle-law.com

Entwistle & Cappucci LLP


Release Versions

Contacts

Andrew J. Entwistle
Entwistle & Cappucci LLP
500 W 2nd Street, Suite 1900
Austin, TX 78701
Telephone: (512) 710-5960
Email: aentwistle@entwistle-law.com
www.entwistle-law.com

More News From Entwistle & Cappucci LLP

Entwistle & Cappucci LLP Files Amended Securities Class Action Complaint Against KnowBe4, Inc. and Related Defendants

NEW YORK--(BUSINESS WIRE)--Entwistle & Cappucci LLP today announced that it filed a First Amended Class Action Complaint (“Complaint”) against KnowBe4, Inc. (“KnowBe4”), certain of KnowBe4’s directors, KKR & Co. Inc., Elephant Partners, Vista Equity Partners Management, LLC (“Vista”) and certain of their affiliates (collectively, “Defendants”) on behalf of a class (“Class”) consisting of all persons or entities that: (a) sold shares of KnowBe4 common stock from October 12, 2022 through...

Entwistle & Cappucci LLP Files a Securities Class Action Against KnowBe4, Inc. and Related Defendants

NEW YORK--(BUSINESS WIRE)--Entwistle & Cappucci LLP today announced that its ongoing investigation has led to the filing of a class action (“Action”) against KnowBe4, Inc. (“KnowBe4”), certain of KnowBe4’s directors, KKR & Co. Inc., Elephant Partners, Vista Equity Partners Management, LLC (“Vista”) and certain of their affiliates (collectively, “Defendants”) on behalf of a class (“Class”) consisting of all persons or entities that: (a) sold shares of KnowBe4 common stock from October 12...

Entwistle & Cappucci LLP Files a Securities Class Action Against Cerevel Therapeutics Holdings, Inc., Bain Capital Investors, LLC and Pfizer, Inc.

NEW YORK--(BUSINESS WIRE)--Entwistle & Cappucci LLP (“Entwistle & Cappucci”) today announced that its ongoing investigation has led to the filing of a class action (the “Action”) against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”), Bain Capital Investors, LLC (“Bain”) and Pfizer, Inc. (“Pfizer”) on behalf of a class (the “Class”) consisting of all persons or entities that: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the perio...
Back to Newsroom